Soligenix Provides Regulatory Update on HyBryte™

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Related Keywords

United States ,Christopherj Schaber , ,Prnewswire Soligenix Inc ,Exchange Commission ,Biomedical Advanced Research ,National Institute Of Allergy ,Soligenix Inc ,European Medicines Agency ,Us Development ,Drug Administration ,Our Public Health Solutions ,Defense Threat Reduction Agency ,Nasdaq ,Linkedin ,Us Congress ,Twitter ,Development Authority ,Chief Executive Officer ,About Cutaneoust Cell Lymphoma ,Public Health Solutions ,National Institute ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,Soligenix ,Nc ,